AstraZeneca, Oxford allowed to resume COVID-19 vaccine trial in U.S. - WSJ

  • 📰 Reuters
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Federal health regulators have decided to allow the resumption of U.S. studies of a leading COVID-19 vaccine candidate from AstraZeneca Plc and the University of Oxford, the Wall Street Journal reported on Friday, citing people familiar with the matter.

FILE PHOTO: A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/File Photo

- Federal health regulators have decided to allow the resumption of U.S. studies of a leading COVID-19 vaccine candidate from AstraZeneca Plc and the University of Oxford, the Wall Street Journal reported on Friday, citing people familiar with the matter.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

easegura Y qué habrá ocurrido con Pfizer (pfizer).

Stock price more important?

WTF! Never try this vaccine, which may be 10 times dangerous than CCP virus itself.

I think this is the one I don't want to try?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WSJ News Exclusive | Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S.Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter. So who wants to die next? ‘According the the person familiar with the matter ‘...alright then. Convenient pump
Source: WSJ - 🏆 98. / 63 Read more »

AstraZeneca, Oxford coronavirus vaccine trial can continue in the US - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Source: BusinessInsider - 🏆 729. / 51 Read more »

WSJ News Exclusive | Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S.Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter. So who wants to die next? ‘According the the person familiar with the matter ‘...alright then. Convenient pump
Source: WSJ - 🏆 98. / 63 Read more »

AstraZeneca resumes U.S. COVID-19 vaccine trial, optimism seen for J&JAstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by U.S. regulators, the company said on Friday. i hv all town police case - 2 y nothing aswer but mine version no normal asks Got a problem? AstraZeneca may be able to help. Ask your doctor if AstraZeneca is right for you. Side effects may include: deadass broke, unable to cough up the $ to save your mom’s life, selling assets, bankruptcy, death bc you deadass broke, and depression We care ❤️❤️🖕 Are we preparing for The Coming of Christ JESUS?
Source: Reuters - 🏆 2. / 97 Read more »

AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue. He received the placebo Shame on you for the incomplete tweet.
Source: Reuters - 🏆 2. / 97 Read more »

AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue. Haa !
Source: Reuters - 🏆 2. / 97 Read more »